1 Cancer Targeted Therapy Market Overview
1.1 Product Overview and Scope of Cancer Targeted Therapy
1.2 Classification of Cancer Targeted Therapy by Types
1.2.1 Global Cancer Targeted Therapy Revenue Comparison by Types (2020-2025)
1.2.2 Global Cancer Targeted Therapy Revenue Market Share by Types in 2018
1.2.3 Tumor Antigens As Targets of Antibodies
1.2.4 Development of Antibodies for Clinical Purposes
1.2.5 Complement Dependent Cytotoxicity (CDC)
1.2.6 Signal Transduction Changes
1.3 Global Cancer Targeted Therapy Market by Application
1.3.1 Global Cancer Targeted Therapy Market Size and Market Share Comparison by Applications (2015-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Cancer Targeted Therapy Market by Regions
1.4.1 Global Cancer Targeted Therapy Market Size (Million USD) Comparison by Regions (2015-2025)
1.4.1 North America (USA, Canada and Mexico) Cancer Targeted Therapy Status and Prospect (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Targeted Therapy Status and Prospect (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Targeted Therapy Status and Prospect (2015-2025)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Targeted Therapy Status and Prospect (2015-2025)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Targeted Therapy Status and Prospect (2015-2025)
1.5 Global Market Size of Cancer Targeted Therapy (2015-2025)
2 Manufacturers Profiles
2.1 Advaxis
2.1.1 Business Overview
2.1.2 Cancer Targeted Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Advaxis Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.2 Bind Therapeutics
2.2.1 Business Overview
2.2.2 Cancer Targeted Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bind Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Cancer Targeted Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.4 Bristol Mayer Squibb
2.4.1 Business Overview
2.4.2 Cancer Targeted Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol Mayer Squibb Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.5 Celldex Therapeutics
2.5.1 Business Overview
2.5.2 Cancer Targeted Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celldex Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.6 Dendreon Corporation
2.6.1 Business Overview
2.6.2 Cancer Targeted Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dendreon Corporation Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.7 Eli Lily
2.7.1 Business Overview
2.7.2 Cancer Targeted Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lily Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.8 GalaxoSmithKline
2.8.1 Business Overview
2.8.2 Cancer Targeted Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GalaxoSmithKline Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.9 Galena Biopharma
2.9.1 Business Overview
2.9.2 Cancer Targeted Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Galena Biopharma Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.10 Genetech
2.10.1 Business Overview
2.10.2 Cancer Targeted Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Genetech Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.11 ImmunoCellular Therapeutics
2.11.1 Business Overview
2.11.2 Cancer Targeted Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 ImmunoCellular Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.12 ImmunoGen
2.12.1 Business Overview
2.12.2 Cancer Targeted Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 ImmunoGen Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.13 Inovio Pharmaceuticals
2.13.1 Business Overview
2.13.2 Cancer Targeted Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Inovio Pharmaceuticals Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.14 Johnson & Johnson
2.14.1 Business Overview
2.14.2 Cancer Targeted Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Johnson & Johnson Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.15 NeoStem Oncology
2.15.1 Business Overview
2.15.2 Cancer Targeted Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 NeoStem Oncology Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.16 NewLink Genetics
2.16.1 Business Overview
2.16.2 Cancer Targeted Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 NewLink Genetics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.17 Northwest Biotherapeutics
2.17.1 Business Overview
2.17.2 Cancer Targeted Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Northwest Biotherapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.18 Merck
2.18.1 Business Overview
2.18.2 Cancer Targeted Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Merck Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.19 Novartis
2.19.1 Business Overview
2.19.2 Cancer Targeted Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Novartis Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.20 Peregrine Pharmaceuticals
2.20.1 Business Overview
2.20.2 Cancer Targeted Therapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Peregrine Pharmaceuticals Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.21 Pfizer
2.21.1 Business Overview
2.2.2 Cancer Targeted Therapy Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Pfizer Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.22 Roche
2.22.1 Business Overview
2.22.2 Cancer Targeted Therapy Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Roche Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.23 Sanofi
2.23.1 Business Overview
2.23.2 Cancer Targeted Therapy Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Sanofi Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.24 Seattle Genetics
2.24.1 Business Overview
2.24.2 Cancer Targeted Therapy Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Seattle Genetics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
2.25 Teva
2.25.1 Business Overview
2.25.2 Cancer Targeted Therapy Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Teva Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2019)
3 Global Cancer Targeted Therapy Market Competition, by Players
3.1 Global Cancer Targeted Therapy Revenue and Share by Players (2015-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Targeted Therapy Players Market Share
3.2.2 Top 10 Cancer Targeted Therapy Players Market Share
3.3 Market Competition Trend
4 Global Cancer Targeted Therapy Market Size by Regions
4.1 Global Cancer Targeted Therapy Revenue and Market Share by Regions
4.2 North America Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
4.3 Europe Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
4.4 Asia-Pacific Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
4.5 South America Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
4.6 Middle East and Africa Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
5 North America Cancer Targeted Therapy Revenue by Countries
5.1 North America Cancer Targeted Therapy Revenue by Countries (2015-2019)
5.2 USA Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
5.3 Canada Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
5.4 Mexico Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
6 Europe Cancer Targeted Therapy Revenue by Countries
6.1 Europe Cancer Targeted Therapy Revenue by Countries (2015-2019)
6.2 Germany Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
6.3 UK Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
6.4 France Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
6.5 Russia Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
6.6 Italy Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
7 Asia-Pacific Cancer Targeted Therapy Revenue by Countries
7.1 Asia-Pacific Cancer Targeted Therapy Revenue by Countries (2015-2019)
7.2 China Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
7.3 Japan Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
7.4 Korea Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
7.5 India Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
7.6 Southeast Asia Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
8 South America Cancer Targeted Therapy Revenue by Countries
8.1 South America Cancer Targeted Therapy Revenue by Countries (2015-2019)
8.2 Brazil Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
8.3 Argentina Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
8.4 Colombia Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
9 Middle East and Africa Revenue Cancer Targeted Therapy by Countries
9.1 Middle East and Africa Cancer Targeted Therapy Revenue by Countries (2015-2019)
9.2 Saudi Arabia Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
9.3 UAE Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
9.4 Egypt Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
9.5 Nigeria Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
9.6 South Africa Cancer Targeted Therapy Revenue and Growth Rate (2015-2019)
10 Global Cancer Targeted Therapy Market Segment by Type
10.1 Global Cancer Targeted Therapy Revenue and Market Share by Type (2015-2019)
10.2 Global Cancer Targeted Therapy Market Forecast by Type (2020-2025)
10.3 Tumor Antigens As Targets of Antibodies Revenue Growth Rate (2015-2025)
10.4 Development of Antibodies for Clinical Purposes Revenue Growth Rate (2015-2025)
10.5 Complement Dependent Cytotoxicity (CDC) Revenue Growth Rate (2015-2025)
10.6 Signal Transduction Changes Revenue Growth Rate (2015-2025)
11 Global Cancer Targeted Therapy Market Segment by Application
11.1 Global Cancer Targeted Therapy Revenue Market Share by Application (2015-2019)
11.2 Cancer Targeted Therapy Market Forecast by Application (2020-2025)
11.3 Hospital Revenue Growth (2015-2019)
11.4 Clinic Revenue Growth (2015-2019)
11.5 Other Revenue Growth (2015-2019)
12 Global Cancer Targeted Therapy Market Size Forecast (2020-2025)
12.1 Global Cancer Targeted Therapy Market Size Forecast (2020-2025)
12.2 Global Cancer Targeted Therapy Market Forecast by Regions (2020-2025)
12.3 North America Cancer Targeted Therapy Revenue Market Forecast (2020-2025)
12.4 Europe Cancer Targeted Therapy Revenue Market Forecast (2020-2025)
12.5 Asia-Pacific Cancer Targeted Therapy Revenue Market Forecast (2020-2025)
12.6 South America Cancer Targeted Therapy Revenue Market Forecast (2020-2025)
12.7 Middle East and Africa Cancer Targeted Therapy Revenue Market Forecast (2020-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
